THE Scarborough family headed by Ian and Merralea Scarborough last night landed a quadrella in the 2021 Hunter Valley Wine and Tourism and Legends Awards. Organised by the Hunter Valley Wine and Tourism Association, before a crowd of more than 300 at a black-tie presentation dinner at Cypress Lakes Resort at Pokolbin, the winners were:… Read More »
May 8th, 2020 Cici Zhou Cardiology, Medicine VitalConnect announced that it has received FDA Emergency Use Authorization status for use of its VitalPatch to detect changes in the QT interval of hospitalized patients undergoing drug treatment for COVID-19. Hydroxychloroquine and chloroquine, used to treat some COVID-19 patients, are associated with risk of prolonged QT interval that… Read More »
March 4th, 2020 Cici Zhou Anesthesiology, Cardiac Surgery, Cardiology, Radiology Cardiovalve announced that it received FDA Breakthrough Device Designation for its Transcatheter Tricuspid Valve Replacement System. The company also received approval for an Early Feasibility Study of the device for tricuspid and mitral valve regurgitation indications. The Cardiovalve transcatheter system is designed for treatment of mitral… Read More »
20 December, 2019, Shenzhen, China – ZTE Corporation (0763.HK / 000063.SZ), a major international provider of telecommunications, enterprise and consumer technology solutions for the mobile Internet, today announced that it has been awarded with the 2019 ATD Excellence in Practice (EIP) Award by Association for Talent Development (ATD) by virtue of the project of “Learning… Read More »
This undated image provided by Novartis shows bottles of Novartis’s Adakveo. U.S. regulators have approved the new sickle cell disease medicine that can prevent extremely painful, dangerous “crises” in which misshapen blood cells clump together, reducing blood and oxygen flow. (Novartis via AP) After a recent decision by the FDA a better day could be… Read More »
Game on. Friday, the FDA approved Novo Nordisk’s Rybelsus—or, as industry watchers know it, oral semaglutide—to control blood sugar in Type 2 diabetes patients. And with the drug boasting stellar data and head-to-head study wins against top products in the field, the green light is expected to majorly shake things up. “This ability to now… Read More »